Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial (CHASM CS- RCT)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The purpose of this study is to compare the effects of low dose prednisone combined with methotrexate to see if it will be as effective, and better tolerated than the standard dose of prednisone alone in the treatment of cardiac sarcoidosis.
- Ages18 years and older
- Trial withOttawa Hospital Research Institute
- Start Date12/15/2020
- End Date12/30/2022
- Last Updated07/15/2021
- Study HIC#2000027643